TheraVacplus treatment elevated levels of effector/memory CD4 and CD8 T cells in tumor tissue and draining lymph nodes and generated activated CD8+ T cells when cocultured with 4T1 cancer cells. This evidence concerns the gene CD8A and neoplasm.